Cargando…
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
Increased mitochondrial function may render some cancers vulnerable to mitochondrial inhibitors. Since mitochondrial function is regulated partly by mitochondrial DNA copy number (mtDNAcn), accurate measurements of mtDNAcn could help reveal which cancers are driven by increased mitochondrial functio...
Autores principales: | Chen, Jiayu, Zheng, Qizhi, Hicks, Jessica L., Trabzonlu, Levent, Ozbek, Busra, Jones, Tracy, Vaghasia, Ajay, Larman, Tatianna C., Wang, Rulin, Markowski, Mark C., Denmeade, Sam R., Pienta, Kenneth J., Hruban, Ralph H., Antonarakis, Emmanuel S., Gupta, Anuj, Dang, Chi V, Yegnasubramanian, Srinivasan, De Marzo, Angelo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979994/ https://www.ncbi.nlm.nih.gov/pubmed/36865273 http://dx.doi.org/10.1101/2023.02.20.529259 |
Ejemplares similares
-
Presence of cells in the polyaneuploid cancer cell (PACC) state predicts the risk of recurrence in prostate cancer
por: Trabzonlu, Levent, et al.
Publicado: (2022) -
Bipolar androgen therapy (BAT): A patient's guide
por: Denmeade, Samuel, et al.
Publicado: (2022) -
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022) -
Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
por: Koh, Cheryl M., et al.
Publicado: (2011) -
Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss
por: Markowski, Mark C., et al.
Publicado: (2022)